# Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome

> **NCT00010400** · NA · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 35 (—)

## Conditions studied

- Systemic Lupus Erythematosus
- Antiphospholipid Antibody Syndrome

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** filgrastim

## Key facts

- **NCT ID:** NCT00010400
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 35 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00010400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00010400, "Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00010400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*